Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Anna Gloyn has been awarded the title of Professor of Molecular Genetics & Metabolism in the University's recent Recognition of Distinction exercise.

Anna is currently a Wellcome Trust Senior Fellow in Basic and Biomedical Science.   

Her research is focused on using naturally occurring mutations in humans as tools to identity critical regulatory pathways and insights into normal physiology

The recognition of distinction exercise is held annually and candidates must meet three criteria for the conferment of the title of full professor. The criteria are research, teaching, and good citizenship.

Anna has also recently been awarded the GB Morgagni Silver Medal.  She will deliver her GB Morgagni Prize lecture in Italy on Friday 31st of October.  The GB Morgagni awards are named after the great Italian anatomist Giovanni Battista Morgagni who was one of the first scientists to carry out research on human anatomy (in Padua) and who laid the foundation for the modern concept of pathology, the G.B. Morgagni Awards Program was instituted in 1984 by a group of postdoctoral researchers working at the University of Padua Medical School.  The Morgagni Prizes were devised and founded by physicians/researchers who were deeply committed to the study and treatment of metabolic diseases. The intention was to promote research on diabetes and its complications, a major public health concern affecting a large portion of the population.

2014 has proven to be a very successful year for Anna.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with


Similar stories

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.